We are live on ! Find out more
BIOC

Biocept, Inc.
BIOC

Delisted

BIOC was delisted on the 24th of October, 2023.

Back to rankings

10 hedge funds and large institutions have $1.16M invested in Biocept, Inc. in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% less capital invested

Capital invested by funds: $1.36M → $1.16M (-$200K)

17% less funds holding

Funds holding: 12 → 10 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$114K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$40K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$20K
3
SCM
Summit Capital Management
Washington
-$17K
4
Citadel Advisors
Citadel Advisors
Florida
-$14K
5
EWM
Edge Wealth Management
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$492K +$114K +3 +27%
BIT
2
BlackRock Institutional Trust
California
$220K – – –
GBA
3
Garrison Bradford & Associates
New York
$149K – – –
Creative Planning
4
Creative Planning
Kansas
$73K – – –
BFA
5
BlackRock Fund Advisors
California
$55K – – –
CC
6
Callan Capital
California
$49K – – –
VKH
7
Virtu KCG Holdings
New York
$34K – – –
Northern Trust
8
Northern Trust
Illinois
$26K – – –
HighTower Advisors
9
HighTower Advisors
Illinois
$21K – – –
SCM
10
Sterneck Capital Management
Missouri
$15K – – –
William Blair & Company
11
William Blair & Company
Illinois
$13K – – –
Morgan Stanley
12
Morgan Stanley
New York
$7K – – –
BIM
13
BlackRock Investment Management
Delaware
$3K – – –
MFS
14
MSI Financial Services
Massachusetts
$2K – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$105 – – –
Bank of America
16
Bank of America
North Carolina
– -$40K -1 Closed
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
– -$20K -1 Closed
Citadel Advisors
18
Citadel Advisors
Florida
– -$14K – –
Citigroup
19
Citigroup
New York
– -$1K – –
EWM
20
Edge Wealth Management
New York
– -$3K – –
Group One Trading
21
Group One Trading
Illinois
– -$1K – –
SCM
22
Summit Capital Management
Washington
– -$17K – –
TRCT
23
Tower Research Capital (TRC)
New York
– -$2K – –
UBS Group
24
UBS Group
Switzerland
– -$1K – –

BIOC Hedge Fund Activity: Q1 2016 in Review

10 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q1 2016, worth a combined $1.16M — down 15% from $1.36M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BIOC and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Vanguard Group, adding an estimated $114K. The largest seller was Bank of America, exiting entirely with an estimated $40K sold.

  • 10 institutional investors held Biocept, Inc. (BIOC) as of Q1 2016, down from 12 in Q4 2015.
  • Funds reported $1.16M of Biocept, Inc. stock for Q1 2016, down 15% quarter-over-quarter.
  • 0 funds opened new Biocept, Inc. positions in Q1 2016 and 2 closed out, a net change of -2 holders.
  • The largest Biocept, Inc. buyer in Q1 2016 was Vanguard Group, an estimated $114K added.
  • The largest Biocept, Inc. seller in Q1 2016 was Bank of America, an estimated $40K sold.

Based on aggregated 13F filings for Q1 2016.